Debut Plus

₹53.8

▼ -0.58 -1.07%

As of 10 Sept 2026 · delayed

BSE Listed

Oxygenta Pharmaceutical Limited (524636)

Volume: 7,746Avg Vol 1W: 17,200Avg Vol 1M: 14,41152W Range:₹43₹74.99
BSE www.oxygentapharma.com AI Report
Key Ratios
Checked 11h ago
Market Cap₹199 Cr
Current Price₹53.8
Previous Close₹54.38
High / Low (52w)₹74.99 / ₹43
Volume7,746
Avg Vol (1W)17,200
Avg Vol (1M)14,411
Stock P/E—
Book Value₹-11.54
Dividend Yield0%
ROE41.16%
ROA-11.34%
Revenue (TTM)—
Revenue Growth—
Profit Margin-10.06%
Total Debt—
Shares Outstanding4 Cr
Face Value—
EPS (TTM)₹0
P/B—
Debt / Equity0
50 DMA₹54.55
200 DMA₹54.09
Day change-1.07%
Price Chart
₹53.8▼ 24.66% · 1Y
₹95₹453.6L
2025-09-11
2026-09-10

20-day avg volume: 13K shares

Pros
  • Healthy return on equity of 41.2%.
  • Company is almost debt-free.
Cons
  • Company is loss-making at the latest annual result.
  • Negative book value per share.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹14 Cr₹33 Cr₹49 Cr₹15 Cr₹14 Cr₹34 Cr₹50 Cr₹37 Cr
EBITDA₹-2 Cr₹-5 Cr₹-1 Cr₹-8 Cr₹-5 Cr₹-5 Cr₹1 Cr₹0 Cr
Net Profit₹-3 Cr₹-4 Cr₹-2 Cr₹-6 Cr₹-5 Cr₹-5 Cr₹-2 Cr₹-2 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹21 Cr₹14 Cr₹52 Cr₹61 Cr₹31 Cr₹40 Cr₹111 Cr₹113 Cr
EBITDA₹-3 Cr₹-9 Cr₹3 Cr₹0 Cr₹-9 Cr₹-12 Cr₹-12 Cr₹-17 Cr
Net Profit₹-3 Cr₹-6 Cr₹3 Cr₹-1 Cr₹-12 Cr₹-3 Cr₹-10 Cr₹-18 Cr
EPS-3.19-5.672.87-0.48-8.15-1.04-2.86-4.75
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹21 Cr₹19 Cr₹34 Cr₹31 Cr₹54 Cr₹63 Cr₹83 Cr₹120 Cr
Total Liabilities₹56 Cr₹60 Cr₹72 Cr₹66 Cr₹100 Cr₹83 Cr₹108 Cr₹162 Cr
Equity₹-35 Cr₹-41 Cr₹-38 Cr₹-35 Cr₹-46 Cr₹-20 Cr₹-26 Cr₹-43 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹-1 Cr₹-2 Cr₹-2 Cr₹-13 Cr₹3 Cr₹-28 Cr
Investing₹-7 Cr₹-5 Cr₹-10 Cr₹-4 Cr₹-11 Cr₹-14 Cr
Financing₹9 Cr₹6 Cr₹11 Cr₹17 Cr₹8 Cr₹43 Cr
Free Cash Flow₹-1 Cr₹-2 Cr₹-2 Cr₹-13 Cr₹3 Cr₹-28 Cr
Shareholding
Promoter 56.54% Institutions 0.03% Public 43.44%
Efficiency & Working Capital
ROCE-26%
Interest Coverage-3.6
Dividend Payout—
Debtor Days32 d
Inventory Days95 d
Payable Days158 d
Cash Conversion Cycle-30 d
Working Capital Days127 d
Shareholding Details

As of 2026-06-30

Promoter56.5%
FII0%
DII0%
Institutions0%
Public43.4%
Promoter Pledge0%
No. of Shareholders10,196
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters29.7%29.7%29.7%33.7%53.3%51.1%51.1%58%58%55.9%56.5%56.5%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public70.2%70.2%70.2%66.3%46.7%48.9%48.9%42%42%44%43.4%43.4%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders8,9729,05110,1029,97010,15410,10710,03010,09410,17910,21510,20510,196
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Virupaksha Organics LimitedShareholding of Promoter and Promoter Group56.5%2.09 Cr
Sravani Reddy GantlaPublic Shareholding6.8%25,07,660
Subba Reddy BhimavarapuPublic Shareholding4.1%15,32,800
Sunil V. ChawdaPublic Shareholding3%10,97,629
Kumuda KatasaniPublic Shareholding2.3%8,38,291
Aakanksha M ChawdaPublic Shareholding1.5%5,69,616
Manoj S. ChawdaPublic Shareholding1.5%5,69,700
Snigdha VankineniPublic Shareholding1.5%5,43,000
Devarapally Venkateswara ReddyPublic Shareholding1.3%4,85,528
Satyanarayana Reddy BandiPublic Shareholding1.3%4,78,159
B Subba ReddyPublic Shareholding1.3%4,67,400
Chandra Mouliswar Reddy GangavaramShareholding of Promoter and Promoter Group0%12,895
Board of Directors
NameDesignationYear
Balasubba Reddy MamillaE D & Wholetime Director2026
Chandra Mouliswar Reddy GangavaramE D & Wholetime Director2026
Sidda Reddy KanuparthiIndependent Non Exe. Director2026
Vedavathi GangavaramNon-Exec & Non-Independent Dir2026
Veera Reddy AravaIndependent Non Exe. Director2026
Sharvari Swapnil ShindeIndependent Non Exe. Director2026
Amireddy Venkatesu ReddyE D & Wholetime Director2026
Janardhana Reddy YeddulaIndependent Non Exe. Director2026
Kumkum BajajCompany Sec. & Compli. Officer2026
Segments — Geography
RegionRevenueShare
Domestic Sales₹113 Cr100%
Export Sales₹0 Cr0%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10383737
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-27Board Meetings—
forthcoming2026-07-25Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2026000118317
2026000112157
20260000185
Insider / Designated-Person Trades

2 recent disclosure(s)

Virupaksha Organics LimitedAcquisition · 2,23,632
Virupaksha Organics LimitedAcquisition · 1,95,885
Substantial Acquisitions (SAST)

3 disclosure(s)

Market13/02/2026 · 2,33,632
Market13/02/2026 · 2,23,632
Market15/12/2025 · 1,95,885
Company Information
Incorporated1990
AuditorA M Reddy & D R Reddy
Investor Email[email protected]; [email protected]; info@sso
🌐 www.oxygentapharma.com ↗

📍 Survey No 252/1 Aroor Village, Sadasivapet Mandal, Medak, Telangana, 502291

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Beryl Drugs Ltd.IEL LimitediStreet Network LimitedGagan Gases Ltd.Parker Agrochem Exports LimitedShukra Pharmaceuticals LimitedArchit Organosys Ltd.Sikozy Realtors LimitedIndo AminesNatural CapsulesWelcure Drugs & Pharmaceuticals Ltd.Bharat Immunological & Biological Corporation Ltd.All “52” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search